113 related articles for article (PubMed ID: 26287341)
1. [Effects of hemoperfusion treatment on serum IL-23 and IL-17 levels in children with Henoch-Schönlein purpure].
Liu L; Huang YP; Fang XL; Zhang YY; Chen N; Hou HH
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Aug; 17(8):796-9. PubMed ID: 26287341
[TBL] [Abstract][Full Text] [Related]
2. [Role of Imbalance between Th17 Cells and Treg Cells in the Pathogenesis of Children with Henoch-Schonlein Purpura].
Wang Q; Shi YY; Cao M; Dong W; Zhang JB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1391-6. PubMed ID: 26524044
[TBL] [Abstract][Full Text] [Related]
3. Increased serum interleukin-17 and peripheral Th17 cells in children with acute Henoch-Schönlein purpura.
Jen HY; Chuang YH; Lin SC; Chiang BL; Yang YH
Pediatr Allergy Immunol; 2011 Dec; 22(8):862-8. PubMed ID: 21929599
[TBL] [Abstract][Full Text] [Related]
4. Effects of hemoperfusion in the treatment of childhood Henoch-Schönlein purpura nephritis.
Chen L; Wang Z; Zhai S; Zhang H; Lu J; Chen X
Int J Artif Organs; 2013 Jul; 36(7):489-97. PubMed ID: 23661557
[TBL] [Abstract][Full Text] [Related]
5. [Clinical effect and mechanism of hemoperfusion in treatment of children with severe abdominal Henoch-Schönlein purpura].
Zhu Y; Dong Y; Xu DL; Jiang JY; Wu L; Ke RJ; Fang SH; Peng Y
Zhongguo Dang Dai Er Ke Za Zhi; 2018 May; 20(5):378-382. PubMed ID: 29764574
[TBL] [Abstract][Full Text] [Related]
6. [Levels of IL-12 produced by dendritic cells and changes of TH1/TH2 balance in children with Henoch-Schonlein purpura].
Sun DQ; Zhang QY; Dong ZY; Bai F
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug; 8(4):307-10. PubMed ID: 16923364
[TBL] [Abstract][Full Text] [Related]
7. Analysis on kidney injury-related clinical risk factors and evaluation on the therapeutic effects of hemoperfusion in children with Henoch-Schonlein purpura.
Ma DQ; Li Y; Han ZG; Zheng M; Xu N; Fan XJ
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3894-3899. PubMed ID: 28975974
[TBL] [Abstract][Full Text] [Related]
8. [Serum levels of IL-5 and LTB4 in children with Henoch-Schonlein purpura].
Liao PY; Wu SH
Zhongguo Dang Dai Er Ke Za Zhi; 2006 Jun; 8(3):198-200. PubMed ID: 16787590
[TBL] [Abstract][Full Text] [Related]
9. Changes of inflammatory mediators and oxidative stress indicators in children with Henoch-Schönlein purpura and clinical effects of hemoperfusion in the treatment of severe Henoch-Schönlein purpura with gastrointestinal involvement in children.
Zhu Y; Dong Y; Wu L; Deng F
BMC Pediatr; 2019 Nov; 19(1):409. PubMed ID: 31684904
[TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of serum levels of IGF-1 and IGFBP-3 in children with Henoch-Schonlein purpura or Henoch-Schonlein purpura nephritis].
Ru L; Abudouhaer A; Guo YF
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Nov; 15(11):1009-13. PubMed ID: 24229600
[TBL] [Abstract][Full Text] [Related]
11. [Roles of serum and urinary interleukins 13Ralpha2 and other cytokines in pediatric Henoch-Schonlein purpura].
Yu YH; Pan KL; Li Q; Zhang BJ; Huang Y; Zhang JJ; DU L
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jan; 11(1):37-40. PubMed ID: 19149920
[TBL] [Abstract][Full Text] [Related]
12. [IL-33 and sST2 levels in Serum of Children with Henoch-Schnlein Purpura and Their Clinical Significance].
Wang F; Dong LL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):517-521. PubMed ID: 28446304
[TBL] [Abstract][Full Text] [Related]
13. [Impact of sera from children with active Henoch-Schönlein purpura on human umbilical venous endothelial cells (HUVECs) and protective effects of methylprednisolone against HUVECs injury].
Wu L; Yuan LP; Fei WJ; Deng F; Zhang Q; Hu B; Lu L
Zhongguo Dang Dai Er Ke Za Zhi; 2012 Jan; 14(1):59-63. PubMed ID: 22289755
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum interleukin-33 levels in patients with Henoch-Schönlein purpura.
Chen T; Jia RZ; Guo ZP; Cao N; Li MM; Jiao XY
Arch Dermatol Res; 2013 Mar; 305(2):173-7. PubMed ID: 22836779
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of the serum biomarker index detection in children with Henoch-Schonlein purpura.
Purevdorj N; Mu Y; Gu Y; Zheng F; Wang R; Yu J; Sun X
Clin Biochem; 2018 Feb; 52():167-170. PubMed ID: 29129626
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of serum high-mobility group protein box 1 in children with Henoch-Schönlein purpura].
Wang FY; Jiang XM; Lu M
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Aug; 17(8):792-5. PubMed ID: 26287340
[TBL] [Abstract][Full Text] [Related]
17. Elevated antilysosomal-associated membrane protein-2 antibody levels in patients with adult Henoch-Schönlein purpura.
Kawakami T; Takeuchi S; Arimura Y; Soma Y
Br J Dermatol; 2012 Jun; 166(6):1206-12. PubMed ID: 22309950
[TBL] [Abstract][Full Text] [Related]
18. An analysis of the levels of the soluble form of the endothelial protein C receptor in children with Henoch-Schönlein Purpura.
Cayci FS; Ekim M; Egin Y; Gökce H; Yalcinkaya F; Ozcakar B; Akar N
Pediatr Hematol Oncol; 2015 Mar; 32(2):115-22. PubMed ID: 24308805
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the change in CD4⁺ T cell subset in children with Henoch-Schonlein purpura.
Li YY; Li CR; Wang GB; Yang J; Zu Y
Rheumatol Int; 2012 Dec; 32(12):3785-92. PubMed ID: 22187057
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin and interleukin-6 levels in Henoch-Schönlein purpura.
Lin CY; Yang YH; Lee CC; Huang CL; Wang LC; Chiang BL
J Microbiol Immunol Infect; 2006 Dec; 39(6):476-82. PubMed ID: 17164950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
